Related Experiment Video
Updated: Jan 25, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Serum Chromium Levels Are Higher in Peritoneal Dialysis than in Hemodialysis Patients
Leonid Feldman1,2, Ilia Beberashvili2,3, Ramzia Abu Hamad2,3
1Nephrology Department, E. Wolfson Medical Center, Holon, Israel leonidf@wmc.gov.il.
Insights
Serum chromium levels are significantly higher in patients undergoing chronic peritoneal dialysis (PD) compared to hemodialysis (HD). This finding highlights differences in chromium accumulation between dialysis modalities.
Area of Science:
- Nephrology
- Clinical Chemistry
- Trace Elements
Background:
- Elevated serum chromium is noted in renal replacement therapy patients.
- Systematic comparison of chromium levels across dialysis modalities is lacking.
Purpose of the Study:
- To compare serum chromium levels in patients undergoing chronic peritoneal dialysis (PD) versus hemodialysis (HD).
Main Methods:
- 169 chronic dialysis patients (148 HD, 21 PD) were studied.
- Serum chromium measured via atomic absorption spectrometry.
- Residual renal function assessed by urine output and GFR.
Main Results:
- Median serum chromium was significantly higher in PD patients (5.00 mcg/L) vs HD patients (1.83 mcg/L).
- PD modality was strongly associated with higher serum chromium (OR 11.87) after multivariate adjustment.
Conclusions:
- Serum chromium levels are elevated in chronic dialysis patients.
- Peritoneal dialysis is independently associated with higher serum chromium levels compared to hemodialysis.
Abstract:
Background:An elevation in serum chromium levels in individuals treated with renal replacement therapy has been previously described, but chromium levels have not been systematically studied in patients treated with different dialysis modalities. The aim of this study was to compare serum chromium levels in patients treated with chronic peritoneal dialysis (PD) and hemodialysis (HD).Methods:We studied 169 chronic dialysis patients in a single medical center, of which 148 were treated with HD and 21 with PD. Serum chromium levels were measured by atomic absorption spectrometry.Residual renal function was accessed using a timed urine collection for the measurement of urine output and calculation of glomerular filtration rate (GFR).Results:The median (interquartile range) serum chromium level was significantly higher in patients treated with PD than in patients treated with HD: 5.00 (3.24 - 6.15) vs 1.83 (1.29 - 2.45) mcg/L, p < 0.001. In a univariate analysis, serum chromium level was associated with PD modality: Exp (B) 7.46 (95% confidence interval [CI] 2.1 - 26.4), p = 0.002. The association of PD modality with serum chromium level was even more significant using a multivariate logistic regression model: odds ratio (OR) 11.87 (95% CI 2.85 - 49.52), p = 0.001 after adjustment for age, gender, diabetes, smoking, dialysis vintage, use of diuretics, and residual renal function.Conclusions:In patients treated with chronic dialysis, serum chromium levels are higher in patients treated with PD than in those treated with HD.
Related Concept Videos
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis III: Nursing Management
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis

